Symbol="FENC"
AssetType="Common Stock"
Name="Fennec Pharmaceuticals Inc"
Description="Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina."
CIK="1211583"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="229692000"
EBITDA="-13009000"
PERatio="None"
PEGRatio="None"
BookValue="-0.368"
DividendPerShare="0"
DividendYield="0"
EPS="-0.98"
RevenuePerShareTTM="0.247"
ProfitMargin="0"
OperatingMarginTTM="-3.667"
ReturnOnAssetsTTM="-0.856"
ReturnOnEquityTTM="-10.06"
RevenueTTM="6537000"
GrossProfitTTM="1449000"
DilutedEPSTTM="-0.98"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="16.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="829.84"
PriceToBookRatio="92.32"
EVToRevenue="722.26"
EVToEBITDA="-12.04"
Beta="0.235"
num_52WeekHigh="10.85"
num_52WeekLow="6.23"
num_50DayMovingAverage="8.63"
num_200DayMovingAverage="8.83"
SharesOutstanding="26419500"
DividendDate="None"
ExDividendDate="None"
symbol="FENC"
open="8.27"
high="8.53"
low="8.11"
price="8.37"
volume="36441.00"
latest_trading_day="2023-08-10"
previous_close="8.20"
change="0.17"
change_percent="2.0732%"
aroon_positive_momentum_days="45"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="45"
Volume_recent_avg="113279"
Change_recent_avg="0.01"
Delta_recent_avg="0.43"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="45"
Aroon_momentum_negative="55"
image_negative_thumbnail_id_1="1112"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0145.jpeg"
image_negative_thumbnail_id_2="158"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0018.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="640"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0068.jpeg"
image_positive_thumbnail_id_2="647"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0061.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
